ACADIA Pharmaceuticals Inc.

LSE:0A4W 주식 보고서

시가총액: US$2.5b

ACADIA Pharmaceuticals 대차 대조표 상태

재무 상태 기준 확인 6/6

ACADIA Pharmaceuticals has a total shareholder equity of $516.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $914.1M and $397.4M respectively. ACADIA Pharmaceuticals's EBIT is $22.8M making its interest coverage ratio -1.1. It has cash and short-term investments of $500.9M.

주요 정보

0%

부채 비율

US$0

부채

이자 보상 비율-1.1x
현금US$500.94m
주식US$516.70m
총 부채US$397.40m
총 자산US$914.10m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: 0A4W's short term assets ($728.9M) exceed its short term liabilities ($337.9M).

장기 부채: 0A4W's short term assets ($728.9M) exceed its long term liabilities ($59.5M).


부채 대 자본 내역 및 분석

부채 수준: 0A4W is debt free.

부채 감소: 0A4W has not had any debt for past 5 years.

부채 범위: 0A4W has no debt, therefore it does not need to be covered by operating cash flow.

이자 보장: 0A4W has no debt, therefore coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기